These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31327654)

  • 1. Review: Quality of herbal medicinal products: State of the art of purity assessment.
    Steinhoff B
    Phytomedicine; 2019 Jul; 60():153003. PubMed ID: 31327654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the quality of herbal medicinal products with a specific focus on contaminants.
    Steinhoff B
    Phytochem Anal; 2021 Apr; 32(2):117-123. PubMed ID: 31402494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolizidine Alkaloid Contamination in Medicinal Plants: Regulatory Requirements and Their Impact on Production and Quality Control of Herbal Medicinal Products.
    Steinhoff B
    Planta Med; 2022 Feb; 88(2):125-129. PubMed ID: 34041723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolizidine alkaloid contamination in herbal medicinal products: Limits and occurrence.
    Steinhoff B
    Food Chem Toxicol; 2019 Aug; 130():262-266. PubMed ID: 31121208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic pyrrolizidine alkaloids in herbal medicines commonly used in Ghana.
    Letsyo E; Jerz G; Winterhalter P; Beuerle T
    J Ethnopharmacol; 2017 Apr; 202():154-161. PubMed ID: 28284793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Perspectives of Pyrrolizidine Alkaloid Contamination in Herbal Medicinal Products.
    Wiesner J
    Planta Med; 2022 Feb; 88(2):118-124. PubMed ID: 34169489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of medicinal plants for public health--European community monographs on herbal substances.
    Knöss W; Chinou I
    Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality Standards for Herbal Drugs and Herbal Drug Preparations - Appropriate or Improvements Necessary?
    Länger R; Stöger E; Kubelka W; Helliwell K
    Planta Med; 2018 Apr; 84(6-07):350-360. PubMed ID: 28850958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herbal drugs: from traditional use to regulation].
    Federici E; Multari G; Gallo FR; Palazzino G
    Ann Ist Super Sanita; 2005; 41(1):49-54. PubMed ID: 16037650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of genotoxicity of herbal medicinal products: application of the "bracketing and matrixing" concept using the example of Valerianae radix (valerian root).
    Kelber O; Wegener T; Steinhoff B; Staiger C; Wiesner J; Knöss W; Kraft K
    Phytomedicine; 2014; 21(8-9):1124-9. PubMed ID: 24837473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracting and Analyzing Pyrrolizidine Alkaloids in Medicinal Plants: A Review.
    Kopp T; Abdel-Tawab M; Mizaikoff B
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32413969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic pyrrolizidine alkaloids provide a warning sign to overuse of the ethnomedicine Arnebia benthamii.
    Ahmad L; He Y; Hao JC; Semotiuk A; Liu QR; Mazari P
    J Ethnopharmacol; 2018 Jan; 210():88-94. PubMed ID: 28807851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contaminants of medicinal herbs and herbal products.
    Kosalec I; Cvek J; Tomić S
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):485-501. PubMed ID: 20061249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of pharmacognosy in pharmacological research on herbal medicinal products.
    Pferschy-Wenzig EM; Bauer R
    Epilepsy Behav; 2015 Nov; 52(Pt B):344-62. PubMed ID: 26169932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe.
    van Galen E
    J Ethnopharmacol; 2014 Dec; 158 Pt B():498-502. PubMed ID: 25043781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The legislative and regulatory framework governing herbal medicine use and practice in Kenya: a review.
    Okumu MO; Ochola FO; Onyango AO; Mbaria JM; Gakuya DW; Kanja LW; Kiama SG; Onyango MA
    Pan Afr Med J; 2017; 28():232. PubMed ID: 29629018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new European legislation on traditional herbal medicines: main features and perspectives.
    Silano M; De Vincenzi M; De Vincenzi A; Silano V
    Fitoterapia; 2004 Mar; 75(2):107-16. PubMed ID: 15030913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European regulation of herbal medicinal products on the border area to the food sector.
    Quintus C; Schweim HG
    Phytomedicine; 2012 Feb; 19(3-4):378-81. PubMed ID: 22070985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.